Updates on treatment of irritable bowel syndrome.

  title={Updates on treatment of irritable bowel syndrome.},
  author={Christopher W Hammerle and Christina M. Surawicz},
  journal={World journal of gastroenterology},
  volume={14 17},
Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder characterized by abdominal pain and discomfort in association with altered bowel habits. It is estimated to affect 10%-15% of the Western population, and has a large impact on quality of life and (in)direct healthcare costs. IBS is a multifactorial disorder involving dysregulation within the brain-gut axis, and it is frequently associated with gastrointestinal motor and sensory dysfunction, enteric and central… CONTINUE READING